Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it can live up to the hype. Icotyde went to market after the Food and Drug Administration approved it in mid-March for moderate to severe plaque psoriasis. The once-a-day drug is the first … Read more
Yet another record week for stocks. Strong first-quarter earnings and a war-driven spike in oil made for another historic week on Wall Street. Investors also made sense of a spate of economic data and the Federal Reserve’s latest interest rate decision. The S & P 500 and Nasdaq Composite gained 0.9% and 1.1%, respectively, over … Read more
You can call it a comeback. Stocks rocketed to record highs last week on hopes of a peace deal with Iran, with the S & P 500 closing above 7,100 for the first time and the Nasdaq completing its longest-winning stretch since 1992 — 13 days of gains. For the week, the broad-based S & … Read more
The stock market staged a comeback last week, even as Wall Street waded through a flurry of both upbeat and unsettling headlines. The Nasdaq broke its five-week losing streak on Friday, buoyed by strong advances from our big tech names like Meta Platforms , Nvidia and Amazon . The tech-heavy index ended the week 1.9% … Read more
A massive market snapback on Friday couldn’t erase all of the week’s damage. After several days of selling, the tech sector roared back, with the Nasdaq gaining over 2% on Friday. Chipmakers Nvidia and Broadcom led the way, with gains of 7.8% and 7.2%, respectively. The broad-based S & P 500 rose nearly 2% in … Read more